Lou Yin, Director of Yuhang Branch of Hangzhou Medical Security Bureau, and his delegation visited Xingyue Biotechnology for research and guidance

On the afternoon of December 18th, Lou Yin, Director of Yuhang Branch of Hangzhou Medical Security Bureau, led a team to visit Xingyue Biotechnology for research and guidance, aiming to gain a deeper understanding of the current development status of Xingyue Biotechnology's medical silk industry. Chen Longkun, Deputy General Manager of Xingyue Biotechnology, and Yu Jin, Office Director, accompanied the reception.

Director Lou conducted comprehensive research on the company's scientific research strength, product technology, and production process. As a leader in the medical silk industry, Xingyue Biotechnology's innovative achievements and industrial layout have been unanimously recognized.

At the symposium, both sides conducted in-depth discussions on the latest developments in medical policies, the path of inclusion in the medical insurance catalog, and information technology construction. Vice General Manager Chen Longkun stated that the medical silk material market has broad prospects and great development potential, especially under the promotion of policies in the biopharmaceutical industry, the company is facing a dual test of opportunities and challenges. At present, the company has launched multiple brands of medical silk products such as Silk Rui Skin, Silk Rui Tai, Silk Xiu Shu, etc. With the excellent biocompatibility and safety of silk fibroin protein, it has initially won good application effects and reputation in the market. The company will also continue to enhance its product innovation capabilities, refine its market positioning, and expand its application areas.

Director Lou and his delegation provided valuable suggestions and guidance on the current development of the company. At the same time, it also deeply interpreted the policy orientation and development trends in the current medical security field, emphasizing the need to increase support for medical technology innovation, especially the clinical application and achievement transformation of new technologies and products in the field of biomedical materials, optimize medical security policies, strengthen the medical regulatory system, and effectively maintain market order to safeguard the stable development of enterprises.

Xingyue Biotechnology will always adhere to the corporate vision of "technology caring for health and technology radiating beauty", actively absorb relevant policy suggestions, strengthen communication and cooperation with relevant departments, continuously improve its scientific research strength and market competitiveness, accelerate the transformation and upgrading of the medical silk industry, and contribute to the global health and beauty cause.